Trial Profile
Treatment of Steroid Non-responsive Acute GVHD With Alpha 1 Antitrypsin (AAT). A Phase I/II Study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Proof of concept
- 22 May 2017 Status changed from active, no longer recruiting to completed.
- 06 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Nov 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.